Advertisement | | Open for Submissions
npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.
Explore the benefits of submitting your manuscript. | | | | | |
TABLE OF CONTENTS
| | | | Volume 6, May 2017 | | In this issue Original Articles Short Communication | | | | Original Articles | Top | | The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancerJ-W Bai, M-N Chen, X-L Wei, Y-Ch Li, H-Y Lin, M Chen, J-W Li, C-W Du, K Man and G-J Zhang Oncogenesis 2017 6: e330; 10.1038/oncsis.2017.38 Abstract | Full Text | | | | Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in gliomaJ-Y Chuang, W-L Lo, C-Y Ko, S-Y Chou, R-M Chen, K-Y Chang, J-J Hung, W-C Su, W-C Chang and T-I Hsu Oncogenesis 2017 6: e339; 10.1038/oncsis.2017.31 Abstract | Full Text | | | | Membrane-bound β-catenin degradation is enhanced by ETS2-mediated Siah1 induction in Helicobacter pylori-infected gastric cancer cellsL Das, S B Kokate, P Dixit, S Rath, N Rout, S P Singh, S E Crowe and A Bhattacharyya Oncogenesis 2017 6: e327; 10.1038/oncsis.2017.26 Abstract | Full Text | | | | Cyclin-dependent kinase 7 is a therapeutic target in high-grade gliomaS A Greenall, Y C Lim, C B Mitchell, K S Ensbey, B W Stringer, A L Wilding, G M O'Neill, K L McDonald, D J Gough, B W Day and T G Johns Oncogenesis 2017 6: e336; 10.1038/oncsis.2017.33 Abstract | Full Text | | | | MicroRNA-645 is an oncogenic regulator in colon cancerS T Guo, X Y Guo, J Wang, C Y Wang, R H Yang, F H Wang, X Y Li, H Hondermarck, R F Thorne, Y F Wang, L Jin, X D Zhang and C C Jiang Oncogenesis 2017 6: e335; 10.1038/oncsis.2017.37 Abstract | Full Text | | | | The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cellsS Koushyar, G Economides, S Zaat, W Jiang, C L Bevan and D A Dart Oncogenesis 2017 6: e333; 10.1038/oncsis.2017.32 Abstract | Full Text | | | | TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex proteinW H Lee, L Y Choong, T H Jin, N N Mon, S Chong, C S Liew, T Putti, S Y Lu, C Harteneck and Y P Lim Oncogenesis 2017 6: e338; 10.1038/oncsis.2017.39 Abstract | Full Text | | | | Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumorsK E Lines, M Stevenson, P Filippakopoulos, S Müller, H E Lockstone, B Wright, S Grozinsky-Glasberg, A B Grossman, S Knapp, D Buck, C Bountra and R V Thakker Oncogenesis 2017 6: e332; 10.1038/oncsis.2017.30 Abstract | Full Text | | | | Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditionsS Murai, A Ando, S Ebara, M Hirayama, Y Satomi and T Hara Oncogenesis 2017 6: e329; 10.1038/oncsis.2017.34 Abstract | Full Text | | | | Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growthH J Nakaoka, Z Tanei, T Hara, J S Weng, A Kanamori, T Hayashi, H Sato, A Orimo, K Otsuji, K Tada, T Morikawa, T Sasaki, M Fukayama, M Seiki, Y Murakami and T Sakamoto Oncogenesis 2017 6: e334; 10.1038/oncsis.2017.27 Abstract | Full Text | | | | The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signallingG Nappo, F Handle, F R Santer, R V McNeill, R I Seed, A T Collins, G Morrone, Z Culig, N J Maitland and H H H Erb Oncogenesis 2017 6: e342; 10.1038/oncsis.2017.23 Abstract | Full Text | | | | Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cellsF Pepe, S Pagotto, S Soliman, C Rossi, P Lanuti, C Braconi, R Mariani-Costantini, R Visone and A Veronese Oncogenesis 2017 6: e328; 10.1038/oncsis.2017.35 Abstract | Full Text | | | | AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stressR U Rasool, D Nayak, S Chakraborty, M M Faheem, B Rah, P Mahajan, V Gopinath, A Katoch, Z Iqra, S K Yousuf, D Mukherjee, L D Kumar, A Nargotra and A Goswami Oncogenesis 2017 6: e341; 10.1038/oncsis.2017.41 Abstract | Full Text | | | | CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifenS Sarkar, A Ghosh, S Banerjee, G Maity, A Das, M A Larson, V Gupta, I Haque, O Tawfik and S K Banerjee Oncogenesis 2017 6: e340; 10.1038/oncsis.2017.43 Abstract | Full Text | | | | miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathwayS-L Tung, W-C Huang, F-C Hsu, Z-P Yang, T-H Jang, J-W Chang, C-M Chuang, C-R Lai and L-H Wang Oncogenesis 2017 6: e326; 10.1038/oncsis.2017.25 Abstract | Full Text | | | | CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patientsC Windmüller, D Zech, S Avril, M Boxberg, T Dawidek, B Schmalfeldt, M Schmitt, M Kiechle and H Bronger Oncogenesis 2017 6: e331; 10.1038/oncsis.2017.29 Abstract | Full Text | | | | Metformin inhibits SUV39H1-mediated migration of prostate cancer cellsT Yu, C Wang, J Yang, Y Guo, Y Wu and X Li Oncogenesis 2017 6: e324; 10.1038/oncsis.2017.28 Abstract | Full Text | | | | α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathwayY Zhao, A Wei, H Zhang, X Chen, L Wang, H Zhang, X Yu, Q Yuan, J Zhang and S Wang Oncogenesis 2017 6: e343; 10.1038/oncsis.2017.40 Abstract | Full Text | | Short Communication | Top | | Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, E K Mai, N H Md Hanafiah, N Lehners, R Penzel, W Weichert, A D Ho, P Schirmacher, H Goldschmidt, M Andrulis and M S Raab Oncogenesis 2017 6: e337; 10.1038/oncsis.2017.36 Abstract | Full Text | | | | | Advertisement | | nature.com webcasts Join us for our upcoming webcast followed by live Q&A: MAKING A NAME IN CANCER IMMUNOTHERAPY Presented by BioPharma Dealmakers Date: Tuesday, 13 June, 2017 Time: 8AM PDT | 11AM EDT | 4PM BST | 5PM CEST REGISTER FOR FREE Sponsored by: Immunomic Therapeutics, Inc., | IsoPlexis | Merus N.V. | Actinium Pharmaceuticals, Inc. | | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment